Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Colista West
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.3233/jpd-179005
10.3233/jpd-179005
The Parkinson disease gene SNCA: evolutionary and structural insights with pathological implication
10.1038/srep24475 · 2016
Current and projected future economic burden of Parkinson’s disease in the U.S
2020
10.1038/nature10324
10.1038/nature10324
Parkinson-causing α-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation
2015
Navigating the dynamic landscape of alpha-synuclein morphology: a review of the physiologically relevant tetrameric conformation
10.4103/1673-5374.265792 · 2020
10.1002/iub.316
10.1002/iub.316
10.1016/j.semcdb.2015.03.008
10.1016/j.semcdb.2015.03.008
10.1523/jneurosci.19-14-05782.1999
10.1523/jneurosci.19-14-05782.1999
The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins
10.1002/prot.24028 · 2012
10.1110/ps.9.12.2489
10.1110/ps.9.12.2489
10.3233/jpd-191702
10.3233/jpd-191702
10.1159/000477990
10.1159/000477990
Structural basis of synaptic vesicle assembly promoted by α-synuclein
10.1038/ncomms12563 · 2016
10.1523/jneurosci.2581-13.2014
10.1523/jneurosci.2581-13.2014
10.1016/j.cell.2005.09.028
10.1016/j.cell.2005.09.028
10.1039/c6mt00026f
10.1039/c6mt00026f
10.1021/acs.biochem.7b00257
10.1021/acs.biochem.7b00257
Mutations in PRKN and SNCA genes important for the progress of Parkinson’s disease
10.2174/1389202914666131210205839 · 2014
Isolation of recombinant tetrameric N-acetylated α-synuclein
10.1016/j.pep.2018.07.008 · 2018
10.1073/pnas.1113260108
10.1073/pnas.1113260108
10.1074/jbc.m111.318949
10.1074/jbc.m111.318949
10.1038/nature16531
10.1038/nature16531
10.4161/idp.26255
10.4161/idp.26255
In-cell NMR spectroscopy of intrinsically disordered proteins
10.1002/pmic.201800055 · 2019
10.1038/nrm3810
10.1038/nrm3810
10.1074/jbc.m411805200
10.1074/jbc.m411805200
Re-designing the α-synuclein tetramer
10.1039/c8cc04054k · 2018
10.1016/j.neulet.2013.04.058
10.1016/j.neulet.2013.04.058
10.1021/ja310518p
10.1021/ja310518p
10.1021/bi501188a
10.1021/bi501188a
10.1038/376191a0
10.1038/376191a0
10.1042/bst0300351
10.1042/bst0300351
How do 14-3-3 proteins work? - Gatekeeper phosphorylation and the molecular anvil hypothesis
10.1016/s0014-5793(01)03288-4 · 2001
10.1038/376188a0
10.1038/376188a0
10.1111/j.1742-4658.2011.08445.x
10.1111/j.1742-4658.2011.08445.x
10.1128/mcb.01636-09
10.1128/mcb.01636-09
The crystal structure of the non-liganded 14-3-3σ protein: Insights into determinants of isoform specific ligand binding and dimerization
10.1038/sj.cr.7290290 · 2005
A binary bivalent supramolecular assembly platform based on cucurbit[8]uril and dimeric adapter protein 14-3-3
10.1002/anie.201701807 · 2017
10.1111/febs.14670
10.1111/febs.14670
10.1074/jbc.ra118.005603
10.1074/jbc.ra118.005603 · doi-reference
Lipid binding inhibits α-synuclein fibril formation
10.1074/jbc.m210136200 · doi-reference
10.1074/jbc.m003738200
10.1074/jbc.m003738200 · doi-reference
Distinct roles of the N-terminal-binding domain and the C-terminal-solubilizing domain of α-synuclein, a molecular chaperone
10.1074/jbc.m111971200 · doi-reference
10.1007/s11064-007-9498-3
10.1007/s11064-007-9498-3 · doi-reference
Neuroprotective function of 14-3-3 proteins in neurodegeneration
10.1155/2013/564534 · doi-reference
Altered gut microbiome in Parkinson’s disease and the influence of lipopolysaccharide in a human α-synuclein over-expressing mouse model
10.3389/fnins.2019.00839 · doi-reference
Alpha-synuclein pathology and the role of the microbiota in Parkinson’s disease
10.3389/fnins.2019.00369 · doi-reference
Downregulation of 14-3-3 proteins in Alzheimer’s disease
10.1007/s12035-019-01754-y · doi-reference
10.1242/jcs.01086
10.1242/jcs.01086 · doi-reference
10.1016/j.semcancer.2006.03.007
10.1016/j.semcancer.2006.03.007 · doi-reference
10.1074/jbc.274.36.25481
10.1074/jbc.274.36.25481 · doi-reference
A role for α-synuclein in the regulation of dopamine biosynthesis
10.1523/jneurosci.22-08-03090.2002 · doi-reference
10.1038/nsmb.3194
10.1038/nsmb.3194 · doi-reference
10.1021/acs.accounts.8b00036
10.1021/acs.accounts.8b00036 · doi-reference
A consensus method for the prediction of “aggregation-prone” peptides in globular proteins
10.1371/journal.pone.0054175 · doi-reference
10.1038/msb.2011.75
10.1038/msb.2011.75 · doi-reference
10.1002/pro.3290
10.1002/pro.3290 · doi-reference
14-3-3 protein sigma isoform co-localizes with phosphorylated α-synuclein in Lewy bodies and Lewy neurites in patients with Lewy body disease
10.1016/j.neulet.2018.03.013 · doi-reference
10.1074/jbc.m600933200
10.1074/jbc.m600933200 · doi-reference
Proteomics analysis identifies phosphorylation-dependent α-synuclein protein interactions
10.1074/mcp.m800116-mcp200 · doi-reference
10.1021/jacs.5b01911
10.1021/jacs.5b01911 · doi-reference
Exploring the structural details of Cu(I) binding to α-synuclein by NMR spectroscopy
10.1021/ja107842f · doi-reference
10.1091/mbc.e06-03-0229
10.1091/mbc.e06-03-0229 · doi-reference
14-3-3 proteins activate Pseudomonas exotoxins-S and -T by chaperoning a hydrophobic surface.
10.1038/s41467-018-06194-1 · doi-reference
10.1016/j.str.2016.12.005
10.1016/j.str.2016.12.005 · doi-reference
10.1038/s41594-019-0365-0
10.1038/s41594-019-0365-0 · doi-reference
10.1073/pnas.0605779103
10.1073/pnas.0605779103 · doi-reference
A structural basis for 14-3-3σ functional specificity
10.1074/jbc.m500982200 · doi-reference